Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Meet Our Editor-in-Chief
Volume: 18 Issue: 1
Author(s): Ryuichi Morishita
Affiliation:
Export Options
About this article
Cite this article as:
Morishita Ryuichi , Meet Our Editor-in-Chief, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2018; 18 (1) . https://dx.doi.org/10.2174/187152221801180905151147
DOI https://dx.doi.org/10.2174/187152221801180905151147 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Related Books
24
2
2
Related Articles
-
Current Perspective and Developments in Electrochemical Sensors Modified
with Nanomaterials for Environmental and Pharmaceutical Analysis
Current Analytical Chemistry Metabolic Syndrome and Cognitive Decline
Current Alzheimer Research Marine Food Protection in Testicular Damages Caused by Diabetes Mellitus
Current Diabetes Reviews Hydrogels: A Journey from Diapers to Gene Delivery
Mini-Reviews in Medicinal Chemistry What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
Current Vascular Pharmacology Nanotechnology Mediated Diagnosis of Type II Diabetes Mellitus
Recent Innovations in Chemical Engineering Disease-Specific iPS Cell Models in Neuroscience
Current Molecular Medicine Induction of Myocardial Fibrosis and Hypertrophy by Natriuretic Peptides
Vascular Disease Prevention (Discontinued) Exploration of Various Proteins for the Treatment of Alzheimer's Disease
Current Drug Metabolism The Potential of Tetrandrine Against Gliomas
Anti-Cancer Agents in Medicinal Chemistry Abietane Diterpenes as Potential Candidates for the Management of Type 2 Diabetes
Current Pharmaceutical Design Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Dietary Modulation of Thymic Enzymes
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetes-induced Alterations in HDL Subfractions Distribution
Current Pharmaceutical Design Regulating the Beta Cell Mass as a Strategy for Type-2 Diabetes Treatment
Current Drug Targets Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors
Inflammation & Allergy - Drug Targets (Discontinued) Novel Approaches for RNA Interference and their Application in Cancer Therapy
Current Pharmacogenomics Oxidative Stress and Psychological Disorders
Current Neuropharmacology Activation of the dsRNA-Activated Protein Kinase PKR in Mitochondrial Dysfunction and Inflammatory Stress in Metabolic Syndrome
Current Pharmaceutical Design